Suppr超能文献

大脑中的Cdk5活性——多种调节途径

Cdk5 activity in the brain - multiple paths of regulation.

作者信息

Shah Kavita, Lahiri Debomoy K

机构信息

Department of Chemistry, 560 Oval Drive, West Lafayette, IN 47907, USA

Laboratory of Molecular Neurogenetics, Departments of Psychiatry and of Medical & Molecular Genetics, Indiana University School of Medicine, Institute of Psychiatric Research, Neuroscience Research Building, 320 W. 15th St., Indianapolis, IN 46202, USA

出版信息

J Cell Sci. 2014 Jun 1;127(Pt 11):2391-400. doi: 10.1242/jcs.147553.

Abstract

Cyclin dependent kinase-5 (Cdk5), a family member of the cyclin-dependent kinases, plays a pivotal role in the central nervous system. During embryogenesis, Cdk5 is indispensable for brain development and, in the adult brain, it is essential for numerous neuronal processes, including higher cognitive functions such as learning and memory formation. However, Cdk5 activity becomes deregulated in several neurological disorders, such as Alzheimer's disease, Parkinson's disease and Huntington's disease, which leads to neurotoxicity. Therefore, precise control over Cdk5 activity is essential for its physiological functions. This Commentary covers the various mechanisms of Cdk5 regulation, including several recently identified protein activators and inhibitors of Cdk5 that control its activity in normal and diseased brains. We also discuss the autoregulatory activity of Cdk5 and its regulation at the transcriptional, post-transcriptional and post-translational levels. We finally highlight physiological and pathological roles of Cdk5 in the brain. Specific modulation of these protein regulators is expected to provide alternative strategies for the development of effective therapeutic interventions that are triggered by deregulation of Cdk5.

摘要

细胞周期蛋白依赖性激酶5(Cdk5)是细胞周期蛋白依赖性激酶家族的成员之一,在中枢神经系统中起着关键作用。在胚胎发育过程中,Cdk5对大脑发育不可或缺,而在成人大脑中,它对众多神经元活动至关重要,包括学习和记忆形成等高级认知功能。然而,在几种神经疾病中,如阿尔茨海默病、帕金森病和亨廷顿病,Cdk5的活性会失调,从而导致神经毒性。因此,精确控制Cdk5的活性对其生理功能至关重要。本述评涵盖了Cdk5调控的多种机制,包括最近发现的几种控制其在正常和患病大脑中活性的Cdk5蛋白激活剂和抑制剂。我们还讨论了Cdk5的自身调节活性及其在转录、转录后和翻译后水平的调控。我们最后强调了Cdk5在大脑中的生理和病理作用。对这些蛋白质调节剂的特异性调节有望为开发因Cdk5失调引发的有效治疗干预措施提供替代策略。

相似文献

1
Cdk5 activity in the brain - multiple paths of regulation.
J Cell Sci. 2014 Jun 1;127(Pt 11):2391-400. doi: 10.1242/jcs.147553.
2
Tale of the Good and the Bad Cdk5: Remodeling of the Actin Cytoskeleton in the Brain.
Mol Neurobiol. 2018 Apr;55(4):3426-3438. doi: 10.1007/s12035-017-0525-3. Epub 2017 May 13.
3
Cyclin-dependent kinases in brain development and disease.
Annu Rev Cell Dev Biol. 2011;27:465-91. doi: 10.1146/annurev-cellbio-092910-154023. Epub 2011 Jul 5.
5
An unusual member of the Cdk family: Cdk5.
Cell Mol Neurobiol. 2008 May;28(3):351-69. doi: 10.1007/s10571-007-9242-1. Epub 2008 Jan 8.
6
Physiological and Pathological Roles of Cdk5: Potential Directions for Therapeutic Targeting in Neurodegenerative Disease.
ACS Chem Neurosci. 2020 May 6;11(9):1218-1230. doi: 10.1021/acschemneuro.0c00096. Epub 2020 Apr 29.
7
A Tale of the Good and Bad: Remodeling of the Microtubule Network in the Brain by Cdk5.
Mol Neurobiol. 2017 Apr;54(3):2255-2268. doi: 10.1007/s12035-016-9792-7. Epub 2016 Mar 5.
8
A review on cyclin-dependent kinase 5: An emerging drug target for neurodegenerative diseases.
Int J Biol Macromol. 2023 Mar 1;230:123259. doi: 10.1016/j.ijbiomac.2023.123259. Epub 2023 Jan 12.
9
Peptides derived from Cdk5 activator p35, specifically inhibit deregulated activity of Cdk5.
Biotechnol J. 2007 Aug;2(8):978-87. doi: 10.1002/biot.200700057.
10
Cdk5: multitasking between physiological and pathological conditions.
Prog Neurobiol. 2011 Jun;94(1):49-63. doi: 10.1016/j.pneurobio.2011.03.006. Epub 2011 Apr 5.

引用本文的文献

1
From Better Diagnostics to Earlier Treatment: The Rapidly Evolving Alzheimer's Disease Landscape.
Medicina (Kaunas). 2025 Aug 14;61(8):1462. doi: 10.3390/medicina61081462.
3
Molecular and Therapeutic Targets for Amyloid-beta Plaques in Alzheimer's Disease: A Review Study.
Basic Clin Neurosci. 2024 Jan-Feb;15(1):1-26. doi: 10.32598/bcn.2021.3522.1. Epub 2024 Jan 1.
5
Structural determinants for activation of the Tau kinase CDK5 by the serotonin receptor 5-HT7R.
Cell Commun Signal. 2024 Apr 19;22(1):233. doi: 10.1186/s12964-024-01612-y.
6
The protective effects of Irbesartan in cognitive impairment in hypertension.
Aging (Albany NY). 2024 Mar 23;16(6):5065-5076. doi: 10.18632/aging.205589.
7
Role of Glutamate Receptor-related Biomarkers in the Etiopathogenesis of ADHD.
Clin Psychopharmacol Neurosci. 2024 Feb 29;22(1):79-86. doi: 10.9758/cpn.23.1056. Epub 2023 Jun 26.
8
Death-associated protein kinase 1 as a therapeutic target for Alzheimer's disease.
Transl Neurodegener. 2024 Jan 9;13(1):4. doi: 10.1186/s40035-023-00395-5.
9
Molecular Changes Associated with Suicide.
Int J Mol Sci. 2023 Nov 24;24(23):16726. doi: 10.3390/ijms242316726.
10
CDK5: an oncogene or an anti-oncogene: location location location.
Mol Cancer. 2023 Nov 23;22(1):186. doi: 10.1186/s12943-023-01895-8.

本文引用的文献

1
Lessons from a BACE1 inhibitor trial: off-site but not off base.
Alzheimers Dement. 2014 Oct;10(5 Suppl):S411-9. doi: 10.1016/j.jalz.2013.11.004. Epub 2014 Feb 12.
2
Cyclin D2 is a GATA4 cofactor in cardiogenesis.
Proc Natl Acad Sci U S A. 2014 Jan 28;111(4):1415-20. doi: 10.1073/pnas.1312993111. Epub 2014 Jan 13.
6
Cyclin I is involved in the regulation of cell cycle progression.
Cell Cycle. 2013 Aug 15;12(16):2617-24. doi: 10.4161/cc.25623. Epub 2013 Jul 11.
7
Immunotherapy for targeting tau pathology in Alzheimer's disease and tauopathies.
Curr Alzheimer Res. 2013 Mar;10(3):217-28. doi: 10.2174/1567205011310030001.
8
Specific inhibition of p25/Cdk5 activity by the Cdk5 inhibitory peptide reduces neurodegeneration in vivo.
J Neurosci. 2013 Jan 2;33(1):334-43. doi: 10.1523/JNEUROSCI.3593-12.2013.
9
p10, the N-terminal domain of p35, protects against CDK5/p25-induced neurotoxicity.
Proc Natl Acad Sci U S A. 2012 Dec 4;109(49):20041-6. doi: 10.1073/pnas.1212914109. Epub 2012 Nov 14.
10
Deregulated Cdk5 triggers aberrant activation of cell cycle kinases and phosphatases inducing neuronal death.
J Cell Sci. 2012 Nov 1;125(Pt 21):5124-37. doi: 10.1242/jcs.108183. Epub 2012 Aug 16.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验